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Developing new therapeutic strategies to achieve a func-
tional cure for HIV infection is a central objective for con-
temporary AIDS research. A key obstacle towards a
functional cure for HIV/AIDS is the paucity of informa-
tion regarding the establishment and maintenance of the
persistent reservoirs of latently HIV-infected cells which
support the rapid reactivation of virus replication when
antiretroviral therapy (ART) is stopped. Given the many
and important similarities between HIV-infection of
humans and SIV infection of macaques, it is very likely
that crucial information on the nature of HIV reservoirs
may come from studies conducted in SIV or SHIV-
infected macaques that are treated with ART. While this
area of AIDS research is still in its early stages, it is impor-
tant to note that these studies have now become possible
due to the availability of antiretroviral regimens that suc-
cessfully reduce SIV or SHIV replication below detectable
limits. Specific advantages of the non-human primate
models for HIV latency, reservoirs and functional cure
include the following: (i) possibility to conduct extensive
characterization of the virus reservoirs and pathogenic
processes in tissues (including elective necropsy); (ii) per-
formance of in vivo pilot trials of new therapeutic
approaches can be conducted in a timely and controlled
fashion; (iii) developing and testing of “risky” interventions
(i.e., cell depletion experiments, stem cell-based interven-
tions etc) that may pose significant ethical challenges in
humans; and (iv) possibility to control for various clinical
parameters that are very hard to control in humans (time
of infection, duration of ART etc). On the other hand, cur-
rent limitations to this type of studies are their cost and
the lack of standardized research resources (i.e., assays,
virus stocks, etc). In this presentation, the potential and
limitations of animal models of functional HIV cure will
be discussed together with selected examples of therapeu-
tic approaches that could be developed and tested in non-
human primates.
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